ACC/AHA Issue Report for CV and Non-CV Complications of COVID-19June 30, 2022
The American College of Cardiology/American Heart Association Task Force on Clinical Data Standards published a report June 23 listing and defining key data elements related to cardiovascular and noncardiovascular complications of COVID-19.
What is the “New Normal” for Medical Residents?November 9, 2020
COVID-19 has upended virtually every aspect of healthcare, including medical education. As the novel coronavirus expanded from a crisis to a pandemic, medical students adjusted to online learning from home. Residents and fellows were told to avoid direct patient care, got pulled into ERs and ICUs to treat COVID-19 patients, or saw clinical rotations canceled altogether.
Evidence and Hope During the PandemicSeptember 2, 2020
Encouraging results were published today, September 2, in JAMA reporting on the reduction in 28-day mortality associated with steroid administration in critically ill COVID-19 patients. The authors reported on their prospective meta-analysis of 7 randomized trials, with a total of 1703 patients, who were randomized to either corticosteroids or placebo (or usual care). There were
Tips to Address the Challenges of non-COVID Care in the Time of a PandemicAugust 10, 2020
In addition to managing the enormous burden of COVID-19 infection and mortality, clinicians are also charged with how we can best provide ongoing regular care for non-COVID patients.
COVID-19: Impact on Cardiovascular Disease Care, Lifelong Learning, and ResearchJuly 27, 2020
In a special report last week, the European Heart Journal spoke to cardiovascular disease (CVD) thought leaders across the globe to gather their insights on the impact of the COVID-19 pandemic on cardiovascular care.
Virtual Care: Time to Develop Your “Screenside” Manner?July 22, 2020
Various healthcare organizations are working to better prepare physicians and advanced practice providers for best practices in providing virtual care.
Post-COVID-19: A New and Improved Normal?July 14, 2020
The pandemic has accelerated the pace of positive change, exposed longstanding racial inequalities that resulted in a disproportionate burden of COVID-19 infection and mortality, and demonstrated new learning needs for health care professionals.
Dexamethasone in the Treatment of COVID-19June 16, 2020
THE RECOVERY TRIAL News emerged from the UK on June 16 around very promising results with dexamethasone in the treatment of COVID-19 infected patients in the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial. RECOVERY is a randomized trial investigating whether treatment with either (1)Lopinavir-Ritonavir, (2)Hydroxychloroquine, (3)Corticosteroids, (4)Azithromycin,(5) Convalescent plasma or (6)Tocilizumab prevents death in patients with COVID-19.
The Endothelium: A Common Denominator Underlying “Atypical” Manifestations of COVID-19?June 15, 2020
A group of Italian researchers recently hypothesized that it is actually the endothelium that is being targeted by the COVID-19 virus.
Multi-System Inflammatory (Kawasaki-Like) Syndrome Associated with COVID-19May 27, 2020
It was initially thought that perhaps children, when infected with COVID-19, developed milder cases which appear clinically like a minor upper respiratory infection. In late April, however, the first published case of a Kawasaki-like disease associated with COVID-19 was described in Hospital Pediatrics.